PURPOSE: To elucidate barriers and facilitators related to glaucoma medication adherence among African Americans (AA) with glaucoma and to elicit input from a community-based participatory research team to guide the development of a culturally informed health promotion program for improving glaucoma medication adherence among AAs. METHODS: The nominal group technique (NGT), a highly structured focus group methodology, was implemented with 12 separate groups of AA patients with glaucoma (N = 89) to identify barriers and facilitators related to glaucoma medication usage. Participant rank-ordering votes were summed across groups and categorized into themes. Next, an individually and culturally targeted health promotion program promoting appropriate medication adherence was developed based on focus group results and input from a community-based participatory research team. RESULTS: The top five barriers included problems with forgetfulness, side effects, cost/affordability, eyedrop administration, and the eyedrop schedule. The most salient top five facilitators were fear or thoughts about the consequences of not taking eyedrops; use of memory aids, cues, or strategies; maintaining a regular routine or schedule for eyedrop administration; ability to afford eyedrops; and keeping eyedrops in the same area. The resulting health promotion program was based on a multicomponent empowerment framework that included glaucoma education, motivational interviewing, and problem-solving training to improve glaucoma medication adherence. CONCLUSIONS: Barriers and facilitators related to glaucoma medication adherence among AAs are multifactorial. Based on the NGT themes and input from the community-based participatory research team, a culturally informed health promotion program was designed and holds great promise for improving medication adherence among this vulnerable population.
PURPOSE: To elucidate barriers and facilitators related to glaucoma medication adherence among African Americans (AA) with glaucoma and to elicit input from a community-based participatory research team to guide the development of a culturally informed health promotion program for improving glaucoma medication adherence among AAs. METHODS: The nominal group technique (NGT), a highly structured focus group methodology, was implemented with 12 separate groups of AA patients with glaucoma (N = 89) to identify barriers and facilitators related to glaucoma medication usage. Participant rank-ordering votes were summed across groups and categorized into themes. Next, an individually and culturally targeted health promotion program promoting appropriate medication adherence was developed based on focus group results and input from a community-based participatory research team. RESULTS: The top five barriers included problems with forgetfulness, side effects, cost/affordability, eyedrop administration, and the eyedrop schedule. The most salient top five facilitators were fear or thoughts about the consequences of not taking eyedrops; use of memory aids, cues, or strategies; maintaining a regular routine or schedule for eyedrop administration; ability to afford eyedrops; and keeping eyedrops in the same area. The resulting health promotion program was based on a multicomponent empowerment framework that included glaucoma education, motivational interviewing, and problem-solving training to improve glaucoma medication adherence. CONCLUSIONS: Barriers and facilitators related to glaucoma medication adherence among AAs are multifactorial. Based on the NGT themes and input from the community-based participatory research team, a culturally informed health promotion program was designed and holds great promise for improving medication adherence among this vulnerable population.
Authors: Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt Journal: Arch Ophthalmol Date: 2012-10
Authors: Felicia Hill-Briggs; Tiffany L Gary; Hsin-Chieh Yeh; Marian Batts-Turner; Neil R Powe; Christopher D Saudek; Frederick L Brancati Journal: J Behav Med Date: 2006-01-06
Authors: John Kasckow; Charlotte Brown; Jennifer Q Morse; Irina Karpov; Salem Bensasi; Stephen B Thomas; Angela Ford; Charles Reynolds Journal: Psychiatr Serv Date: 2010-07 Impact factor: 3.084
Authors: Felicia Hill-Briggs; Denise C Cooper; Kimberly Loman; Frederick L Brancati; Lisa A Cooper Journal: Diabetes Educ Date: 2003 Nov-Dec Impact factor: 2.140
Authors: Catherine Slota; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Betsy Sleath Journal: Optom Vis Sci Date: 2015-05 Impact factor: 1.973
Authors: Laura E Dreer; Cynthia Owsley; Lisa Campbell; Liyan Gao; Andy Wood; Christopher A Girkin Journal: Curr Eye Res Date: 2015-01-27 Impact factor: 2.424
Authors: Andrew Camp; Sarah R Wellik; Jonathan H Tzu; William Feuer; Kristopher L Arheart; Ananth Sastry; Anat Galor Journal: Cont Lens Anterior Eye Date: 2015-02-24 Impact factor: 3.077
Authors: Omar A Halawa; Ajay Kolli; Gahee Oh; William G Mitchell; Robert J Glynn; Dae Hyun Kim; David S Friedman; Nazlee Zebardast Journal: Ophthalmology Date: 2021-10-06 Impact factor: 12.079
Authors: Brent Siesky; Alon Harris; Aditya Belamkar; Ryan Zukerman; Avery Horn; Alice Verticchio Vercellin; Kristen A Mendoza; Paul A Sidoti; Francesco Oddone Journal: J Glaucoma Date: 2022-03-29 Impact factor: 2.290
Authors: Betsy Sleath; Scott A Davis; Delesha M Carpenter; Alan L Robin; Kelly W Muir; Charles Lee; Nacire Garcia; Donald L Budenz Journal: Optom Vis Sci Date: 2020-07 Impact factor: 2.106